1h
MarketBeat on MSNNovo Nordisk Shares Near New 52-Week Low: Analysts See Big UpsideShares of weight loss and diabetes medication maker Novo Nordisk (NYSE: NVO) have slumped precipitously over the past 52 ...
JPMorgan analyst Adrian Huerta lowered the firm’s price target on Cementos Pacasmayo (CPAC) to $6 from $6.50 and keeps an Underweight rating on ...
In a report released on February 13, Michele Della Vigna from Goldman Sachs maintained a Buy rating on Neste Corporation (0O46 – Research ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results